Affiliation:
1. Institute of Pathophysiology Faculty of Medicine University of Ljubljana Ljubljana Slovenia
2. Laboratory for Neuro‐ and Psychophysiology Department of Neurosciences KU Leuven Leuven Belgium
3. Center for Clinical Physiology Faculty of Medicine University of Ljubljana Ljubljana Slovenia
Abstract
AbstractIntroductionPast research on Alzheimer's disease (AD) has focused on biomarkers, cognition, and neuroimaging as primary predictors of its progression, albeit additional ones have recently gained attention. When turning to the prediction of the progression from one stage to another, one could benefit from the joint assessment of imaging‐based biomarkers and risk/protective factors.MethodsWe included 86 studies that fulfilled our inclusion criteria.ResultsOur review summarizes and discusses the results of 30 years of longitudinal research on brain changes assessed with neuroimaging and the risk/protective factors and their effect on AD progression. We group results into four sections: genetic, demographic, cognitive and cardiovascular, and lifestyle factors.DiscussionGiven the complex nature of AD, including risk factors could prove invaluable for a better understanding of AD progression. Some of these risk factors are modifiable and could be targeted by potential future treatments.
Subject
Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献